West Australian Neurologist Appointed President Of The World Federation Of Neurology
West Australian Professor William (Bill) Carroll has been elected President of the World Federation of Neurology (WFN) during the 23rd World Congress of Neurology currently being held in Kyoto Japan. He will assume the office of President from January 1st 2018.
Professor Carroll, a neurologist at Sir Charles Gairdner Hospital and multiple sclerosis (MS) clinician and researcher at the Perron Institute for Neurological and Translational Science (Perron Institute), has been recognised for decades as a leader in the field of MS treatment and research.
Professor Carroll said that he was “deeply honoured by his nomination and appointment and his intention is to create a collaborative approach to achieve the goals of the WFN.” For the next four years, Professor Carroll has a strong vision for the WFN, particularly in the areas of education, equality in neurological care and encouraging the younger generation of neurologists.
When Professor Carroll turned his attention to MS research 25 years ago, no treatments existed and diagnosis was often difficult. Many sufferers have relapsing-remitting MS, and in Australia today, treatment is readily accessible. Professor Carroll’s focus now is to shift attention onto progressive MS and reduce the significant disabling effects of this condition.
“It is a very promising time at the moment, with an unstoppable momentum locally and globally including the World Health Organisation’s initiative for non-communicable diseases such as dementia, MS and stroke,” said Professor Carroll.
A prominent leader and member of the London-based WFN for 18 years, Professor Carroll has held many and varied roles within the Federation. These include First Vice President and Chair of the Fundraising Committee, and current positions include Chair of the Congress Committee since 2014 and Chair of the Global Neurology Network since 2013.
Professor Carroll has also played critical roles in establishing groups such as the Pan-Asian Committee for the Treatment, Research, and Investigation of Multiple Sclerosis (PACTRIMS), and advocating for MS awareness worldwide.
“We are delighted with the news of Professor Carroll becoming President of the WFN and wish him every success in his new role,” said Perron Institute CEO, Steve Arnott.
“His recognition as an eminent clinician and researcher, and now his elevation to the highest position in his field, is testament to his global standing. As West Australians we should be very proud of Professor Carroll’s achievements. ”
Currently, Professor Carroll is also a Multiple Sclerosis WA Board Director, Chair of the Multiple Sclerosis Research Australia International Research Review Board and Foundation Vice President of PACTRIMS, the Asia Pacific editor of Multiple Sclerosis Journal, and member of the International Progressive MS Alliance Scientific Steering Committee.
Previous appointments include Chair of the Multiple Sclerosis Research Australia Research Management Council, member Board of Multiple Sclerosis Australia, President of the Australian and New Zealand Association of Neurologists and President of the XVIII World Congress of Neurology in 2005.
In 2012, Professor Carroll was awarded the West Australian of the Year Award (Business & Professions) in recognition of his passion and dedication to MS research.
ENDS
MEDIA CONTACT
Tennille Kroemer
0426 044 223
tennille.kroemer@perron.uwa.edu.au
BACKGROUND
Perron Institute for Neurological and Translational Science
• For 35 years, the Perron Institute, formerly the WA Neuroscience Research Institute (WANRI), (WA's longest established medical research institute) has provided residence to a world-class standard of medical researchers and specialists who have made significant breakthroughs across a broad spectrum of neurological conditions.
• The Perron Institute has facilities within the Queen Elizabeth II Medical Centre and Murdoch University and brings together laboratory scientists, neurologists, neurosurgeons, clinical psychologists, physiotherapists and other health professionals to tackle the major challenges in neurology.
Professor Carroll, a neurologist at Sir Charles Gairdner Hospital and multiple sclerosis (MS) clinician and researcher at the Perron Institute for Neurological and Translational Science (Perron Institute), has been recognised for decades as a leader in the field of MS treatment and research.
Professor Carroll said that he was “deeply honoured by his nomination and appointment and his intention is to create a collaborative approach to achieve the goals of the WFN.” For the next four years, Professor Carroll has a strong vision for the WFN, particularly in the areas of education, equality in neurological care and encouraging the younger generation of neurologists.
When Professor Carroll turned his attention to MS research 25 years ago, no treatments existed and diagnosis was often difficult. Many sufferers have relapsing-remitting MS, and in Australia today, treatment is readily accessible. Professor Carroll’s focus now is to shift attention onto progressive MS and reduce the significant disabling effects of this condition.
“It is a very promising time at the moment, with an unstoppable momentum locally and globally including the World Health Organisation’s initiative for non-communicable diseases such as dementia, MS and stroke,” said Professor Carroll.
A prominent leader and member of the London-based WFN for 18 years, Professor Carroll has held many and varied roles within the Federation. These include First Vice President and Chair of the Fundraising Committee, and current positions include Chair of the Congress Committee since 2014 and Chair of the Global Neurology Network since 2013.
Professor Carroll has also played critical roles in establishing groups such as the Pan-Asian Committee for the Treatment, Research, and Investigation of Multiple Sclerosis (PACTRIMS), and advocating for MS awareness worldwide.
“We are delighted with the news of Professor Carroll becoming President of the WFN and wish him every success in his new role,” said Perron Institute CEO, Steve Arnott.
“His recognition as an eminent clinician and researcher, and now his elevation to the highest position in his field, is testament to his global standing. As West Australians we should be very proud of Professor Carroll’s achievements. ”
Currently, Professor Carroll is also a Multiple Sclerosis WA Board Director, Chair of the Multiple Sclerosis Research Australia International Research Review Board and Foundation Vice President of PACTRIMS, the Asia Pacific editor of Multiple Sclerosis Journal, and member of the International Progressive MS Alliance Scientific Steering Committee.
Previous appointments include Chair of the Multiple Sclerosis Research Australia Research Management Council, member Board of Multiple Sclerosis Australia, President of the Australian and New Zealand Association of Neurologists and President of the XVIII World Congress of Neurology in 2005.
In 2012, Professor Carroll was awarded the West Australian of the Year Award (Business & Professions) in recognition of his passion and dedication to MS research.
ENDS
MEDIA CONTACT
Tennille Kroemer
0426 044 223
tennille.kroemer@perron.uwa.edu.au
BACKGROUND
Perron Institute for Neurological and Translational Science
• For 35 years, the Perron Institute, formerly the WA Neuroscience Research Institute (WANRI), (WA's longest established medical research institute) has provided residence to a world-class standard of medical researchers and specialists who have made significant breakthroughs across a broad spectrum of neurological conditions.
• The Perron Institute has facilities within the Queen Elizabeth II Medical Centre and Murdoch University and brings together laboratory scientists, neurologists, neurosurgeons, clinical psychologists, physiotherapists and other health professionals to tackle the major challenges in neurology.